Avalyn Pharma Inc. Common Stock

NASDAQ:AVLN

Medical - Pharmaceuticals

Healthcare
$27.69 +1.77%

+$0.52 today

Market cap
$1.23B
Beta
0.00
52W Low $24.15High $32.23

Volume 0.40M

Average 0.51M

AVLN Accounts Receivables

Cash effect of the change in amounts owed by customers; growing receivables consume cash.

No reported Accounts Receivables figures are available to summarize.

Accounts Receivables history

Currency unavailable · from the cash flow

No Accounts Receivables data reported for this period type.

Accounts Receivables vs competitors

How AVLN compares with its peers on the latest reported figures

AVLN Competitors
Accounts Receivables for AVLN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
INSMInsmed IncorporatedLTM Jun 2026$162.88M USD+1189.3%+139.6%14.3%
MNKDMannKind CorporationLTM Mar 2026$22.62M USD+351.7%-26.1%6.3%
VCREVicore Pharma Holding ABLTM Jun 2026SEK 8.69M SEK+561.8%+24.4%653.7%
GYREGyre Therapeutics, Inc.LTM Mar 2026$3M USD-61.4%+14.7%2.6%
AVLNAvalyn Pharma Inc. Common Stock—— ———
Peer median (excluding AVLN) —+456.8%+19.6%10.3%

Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Avalyn Pharma Inc. Common Stock

NASDAQ:AVLN

Intrinsic Alpha fair value

Locked

Current Price

$27.69

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.